Four novel microcin B17-like biosynthetic gene clusters from environmental Pseudomonas produced structurally similar peptide antibiotics with unexpectedly distinct physiological effects on host cells.
4 novel BGCsGenome mining identified four new MccB17-like antimicrobial peptide gene clusters from environmental Pseudomonas
What the researchers found
Four MccB17-like BGCs from Pseudomonas produced modified peptides that caused growth retardation and cell elongation in E. coli, with transcriptomics revealing congener-specific stress responses despite structural similarity.
Why it matters
Expanding the diversity of known antibiotic peptides beyond well-studied species could yield new antimicrobial leads. The finding that similar peptides trigger different responses highlights untapped functional diversity in natural peptide antibiotics.
How the study worked
Genome mining for BGC identification, heterologous expression in E. coli, RT-qPCR and LC-MS confirmation of peptide production, overlay antimicrobial assays, and RNA-Seq transcriptome profiling.
What this study cannot tell us
No detectable antibacterial activity in standard overlay assays—the peptides' biological activity may be subtler or require different test conditions. Only expressed in E. coli as a heterologous host. Environmental relevance of these peptides is unknown.
How to read the evidence
Discovery-stage research with thorough molecular characterization. Novel findings about peptide diversity, but therapeutic application is speculative at this stage.
When this study was published
Published in 2025, advancing genome mining approaches for antimicrobial peptide discovery.
The bigger picture
This work demonstrates that genome mining of environmental bacteria can reveal novel antimicrobial peptide variants with potentially unique biological activities, expanding the toolkit for antibiotic development beyond well-characterized species.
Questions still open
- Could these MccB17 congeners show antibacterial activity under different assay conditions or against different target bacteria?
- What structural modifications account for the congener-specific physiological effects?
- Can these novel peptide variants be optimized for stronger antimicrobial activity?
Common questions
What is microcin B17?
Why look for similar peptides in other bacteria?
Read the original research
Heterologous expression and functional characterization of novel microcin B17 congeners from environmental Pseudomonas isolates.
Applied microbiology and biotechnology, 110(1), 45
Citation
De Smedt, Sandrien; Wéry, Dries; Vande Capelle, Hanne; Gerstmans, Hans; Monsieurs, Pieter; Masschelein, Joleen; Ruelens, Philip; Fauvart, Maarten; Michiels, Jan. (2026). Heterologous expression and functional characterization of novel microcin B17 congeners from environmental Pseudomonas isolates.. Applied microbiology and biotechnology, 110(1), 45. https://doi.org/10.1007/s00253-025-13698-6